Back to Search
Start Over
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents
- Source :
- Endocrinology and Metabolism Clinics of North America. 50:179-191
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Osteoporosis is characterized by reduced bone mass leading to diminished skeletal integrity and an increased risk for fracture. Multiple agents exist that are effective for the treatment of osteoporosis. These can be broadly categorized into those that reduce the risk for additional loss of bone mass (anti-resorptive agents) and those that augment existing bone mass (anabolic agents). This article reviews the different medications within each class, and discusses more recent data regarding the combination and sequential use of these medications for optimization of skeletal health in patients at high risk for fracture.
- Subjects :
- Bone Density Conservation Agents
business.industry
Endocrinology, Diabetes and Metabolism
Osteoporosis
030209 endocrinology & metabolism
medicine.disease
Bioinformatics
Anabolic Agents
3. Good health
Fractures, Bone
03 medical and health sciences
0302 clinical medicine
Endocrinology
Increased risk
Bone Density
030220 oncology & carcinogenesis
medicine
Humans
In patient
Augment
business
Bone mass
Subjects
Details
- ISSN :
- 08898529
- Volume :
- 50
- Database :
- OpenAIRE
- Journal :
- Endocrinology and Metabolism Clinics of North America
- Accession number :
- edsair.doi.dedup.....c4e5815cdae6919d4f62c60f2b92f47d